[The origin of hypertrophic cardiomyopathy].
The author describes the clinical cases of hypertrophic cardiomyopathy (CMP). The development of obstructive CMP in a patient with hyperparathyroidism indicates a possible pathogenetic role of endocrine factors and calcium metabolism abnormalities. The familial character of the disease and its combination with hereditary diseases (familial microspherocytosis) point to the significance of genetic factors. In addition, marked hypertrophy of the myocardium (without dilatation) including hypertrophy with obstruction of the outflow tract of the left ventricle was observed in nonspecific protracted myocarditis, alcoholic injury to the heart, in athletes, in coronary heart disease (after survival of myocardial infarction). It is suggested that hypertrophic CMP (similarly to restrictive and congestive CMP) is most likely a syndrome of varying origin.
D000241:Adenosine / Q000378:metabolism; D000328:Adult; D000437:Alcoholism / Q000150:complications; D000818:Animals; D002312:Cardiomyopathy, Hypertrophic / Q000175:diagnosis / Q000209:etiology* / Q000235:genetics; D002395:Catecholamines / Q000378:metabolism; D003937:Diagnosis, Differential; D004285:Dogs; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D051381:Rats; D013103:Spherocytosis, Hereditary / Q000150:complications
D002395:Catecholamines; D000241:Adenosine
K voprosu o proiskhozhdenii gipertroficheskoĭ kardiomiopatii.